Filing Flows › Alamar Biosciences (ALMR) › Next earnings date
Alamar Biosciences (ALMR) earnings: missed the estimate
Alamar Biosciences (ALMR) reported on Nov 3, 2026 and missed the EPS estimate: −$0.19 against −$0.19 (-1.7%). Revenue was $33.5M for Q3 2026, +68% year over year. It beat the EPS estimate in 50% of the quarters on record.
The last report
Alamar Biosciences reported revenue of $33.5M for the third quarter 2026 (+68% Y/Y), net loss $13.3M: Product $26.3M, Service Other $7.2M. How it makes money → · Every quarter →
Alamar Biosciences' latest quarter
Alamar Biosciences, Q3 2026: revenue $33.5M (+68% year over year), operating margin -45.1%, net loss $13.3M, operating cash flow −$14.7M. The chart follows the revenue to costs, profit and cash.
Questions
Did Alamar Biosciences beat earnings?
Alamar Biosciences (ALMR) reported on Nov 3, 2026 and missed the EPS estimate: −$0.19 against −$0.19 (-1.7%).
When does ALMR report earnings?
The next date is not set yet.
Does Alamar Biosciences usually beat earnings?
It beat the consensus EPS estimate in 50% of the quarters on record.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.